Immunotherapy to treat sepsis induced-immunosuppression: Immune eligibility or outcome criteria, a systematic review
Author:
Funder
APHP
Publisher
Elsevier BV
Subject
Critical Care and Intensive Care Medicine
Reference36 articles.
1. Assessment of global incidence and mortality of hospital-treated Sepsis. Current estimates and limitations;Fleischmann;Am J Respir Crit Care Med,2016
2. Current gaps in sepsis immunology: new opportunities for translational research;Rubio;Lancet Infect Dis,2019
3. Cytokine storm and sepsis disease pathogenesis;Chousterman;Semin Immunopathol,2017
4. The next generation of Sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*;Opal;Crit Care Med,2014
5. The immunopathology of sepsis and potential therapeutic targets;van der Poll;Nat Rev Immunol,2017
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current perspectives in the management of sepsis and septic shock;Frontiers in Medicine;2024-08-15
2. Lobetyolin protects mice against LPS-induced sepsis by downregulating the production of inflammatory cytokines in macrophage;Frontiers in Pharmacology;2024-05-10
3. Protein modification by short-chain fatty acid metabolites in sepsis: a comprehensive review;Frontiers in Immunology;2023-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3